Quantitative evaluation of protein expression as a function of tissue microarray core diameter: Is a large (1.5 mm) core better than a small (0.6 mm) core?

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 4, 2010, Pages 613-619

  Anagnostou, Valsamo K ^a   Lowery, Frank J ^a   Syrigos, Konstantinos N ^a   Cagle, Philip T ^b   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR PROTEIN;

ALGORITHM; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; METHODOLOGY; NEOPLASM; PATHOLOGY; PROTEIN MICROARRAY; STATISTICS; TISSUE MICROARRAY;

ALGORITHMS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ARRAY ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 77950531020     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol. 2001;70(3):255-264. (Pubitemid 32607198)
2. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for highthroughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844-847. (Pubitemid 28331029)
3. Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M. Tissue microarray: a new technology for amplification of tissue resources. Cancer J. 2001;7(1):24-31. (Pubitemid 32199100)
4. Giltnane JM, Rimm DL. Technology insight: identification of biomarkers with tissue microarray technology. Nat Clin Pract. 2004;1(2):104-111. (Pubitemid 40823750)
5. Iakovlev VV, Pintilie M, Morrison A, Fyles AW, Hill RP, Hedley DW. Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX. Lab Invest. 2007;87(12):1206-1217. (Pubitemid 350126705)
6. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol. 2001;159(6):2249-2256. (Pubitemid 33104278)
7. Chung GG, Zerkowski MP, Ghosh S, Camp RL, Rimm DL. Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest. 2007; 87(7):662-669. (Pubitemid 46920099)
8. McCabe A, Dolled-Filhart M, Camp RL, Rimm DL. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Nat Cancer Inst. 2005;97(24):1808-1815. (Pubitemid 43033901)
9. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002;8(11): 1323-1327. (Pubitemid 35373567)
10. Sahin F, Kannangai R, Adegbola O, Wang J, Su G, Torbenson M. mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res. 2004; 10(24):8421-8425. (Pubitemid 40053405)
11. Camp RL, Neumeister V, Rimm DL. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol. 2008;26(34):5630-5637.
12. Mills SE, Fechner RE, Frierson HF, et al. Guardians of the wax and the patient. Am J Clin Pathol. 1995;104(4):365-367.
13. Layfield LJ, Saria E, Mooney EE, Liu K, Dodge RR. Tissue heterogeneity of immunohistochemically detected estrogen receptor: implications for image analysis quantification. Am J Clin Pathol. 1998;110(6):758-764. (Pubitemid 28541552)
14. Moch H, Schraml P, Bubendorf L, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol. 1999;154(4):981-986. (Pubitemid 29169731)
15. Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res. 1999;5(8): 1966-1975. (Pubitemid 29399245)
16. Kyndi M, Sorensen FB, Knudsen H, et al. Tissue microarrays compared with whole sections and biochemical analyses: a subgroup analysis of DBCG 82 b&c. Acta Oncol. 2008;47(4):591-599. (Pubitemid 351878434)
17. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80(12):1943-1949.
18. Nocito A, Bubendorf L, Tinner EM, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol. 2001;194(3):349-357. (Pubitemid 32624562)
19. Garcia JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood. 2003;101(2):681-689. (Pubitemid 36077593)
20. Robinson BD, YL, Ingram C, Rohan T, Condeelis J, Jones JG. Quantitation of TMEM (tumor microenvironment of metastasis) in human primary breast cancer samples is predictive of long-term metastatic potential. United States and Canadian Academy of Pathology Annual Meeting; 2008. Abstract 1504.